Literature DB >> 770085

Azapropazone - its place in the management of rheumatoid conditions.

P M Brooks, W W Buchanan.   

Abstract

The authors review the trials carried out on azapropazone in rheumatoid arthritis and other rheumatoid conditions. They comment that in terms of efficacy azapropazone would appear to be a useful non-steroidal anti-inflammatory analgesic which compares favourably with other established antirheumatic agents against which it has been tested. Its main advantages are its low incidence of side-effects and the fact that in the majority of the trials reported azapropazone treatment was preferred by patients to that with other agents.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 770085     DOI: 10.1185/03007997609109288

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  2 in total

1.  Disposition of azapropazone in chronic renal and hepatic failure.

Authors:  K H Breuing; H J Gilfrich; T Meinertz; U W Wiegand; E Jähnchen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 2.  Classical absorption theory and the development of gastric mucosal damage associated with the non-steroidal anti-inflammatory drugs.

Authors:  K McCormack; K Brune
Journal:  Arch Toxicol       Date:  1987-06       Impact factor: 5.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.